These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9486389)

  • 41. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
    Lopalco L; Pastori C; Cosma A; Burastero SE; Capiluppi B; Boeri E; Beretta A; Lazzarin A; Siccardi AG
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):109-15. PubMed ID: 10659050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
    de Santis C; Lopalco L; Robbioni P; Longhi R; Rappocciolo G; Siccardi AG; Beretta A
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):157-62. PubMed ID: 7515259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.
    Verrier F; Burda S; Belshe R; Duliege AM; Excler JL; Klein M; Zolla-Pazner S
    J Virol; 2000 Nov; 74(21):10025-33. PubMed ID: 11024131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    J Infect Dis; 1995 Sep; 172(3):897-8. PubMed ID: 7658093
    [No Abstract]   [Full Text] [Related]  

  • 47. [The immunoenzyme test system for detection of HIV-1 antigens based on using immune polyclonal anti-HIV serum and monoclonal antibodies against gene GAG HIV-1 proteins].
    Trushinskaia GN; Simonov VI; Makarova NE; Nosik DN; Kushch AA; Gibadulin RA
    Vestn Ross Akad Med Nauk; 1992; (9-10):43-7. PubMed ID: 1283720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P; Gairin JE; Bénichou S; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.
    Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK
    Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).
    Bao MJ; Geng WQ; Cui HL; Zhang XL; Xu DB; Nian H; Dai D; Wang YN; Shang H
    Mol Med Rep; 2012 May; 5(5):1311-7. PubMed ID: 22344547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-idiotypic antisera raised against monoclonal antibody specific for a p24 gag region epitope detects a common interspecies idiotype associated with anti-HIV responses.
    Morrow WJ; Gaston I; Anderson T; Haigwood N; McGrath MS; Rosen J; Steimer KS
    Viral Immunol; 1990; 3(2):99-109. PubMed ID: 1694432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
    St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies reactive with non-polymorphic epitopes on HLA molecules cause false-positive HIV antibody tests on African samples of serum.
    Aceti A; Terzaroli P; Paparo BS; Celestino D; Sebastiani A; Bile K; Tanigaki N; Tosi R; Ameglio F
    J Infect; 1990 Jan; 20(1):84-6. PubMed ID: 1688903
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversal of immunosuppression of lymphocyte proliferation caused by sera from persons with AIDS.
    Tomar RH; John P; Hinds P
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):408-11. PubMed ID: 7583915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus.
    McChesney MB; Oldstone MB
    Adv Immunol; 1989; 45():335-80. PubMed ID: 2665441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.